David Palma: Do All Patients With Oligometastatic Disease Need SBRT?
David Palma

David Palma: Do All Patients With Oligometastatic Disease Need SBRT?

David Palma, Radiation Oncologist at London Health Sciences Centre (LHSC), Professor at Western University, shared a post on LinkedIn:

Are oligometastatic cancers curable? And should all patients with oligomets receive SBRT?

Check out our editorial on chad tang’s EXTEND RCT, led by our graduating resident Vivian Tan.”

Title: EXTENDing the Role of Radiation in Oligometastatic Disease

Authors: Vivian S. Tan and  David A. Palma

Read The Full Article

David Palma

Other articles about SBRT on OncoDaily.